- Who can participate: Adults aged 18 to 65 with a diagnosis of hypertension may be eligible. Exclusion criteria include pregnancy, current use of other investigational drugs, and significant cardiovascular conditions.
- Study details: Participants will undergo initial screening to confirm eligibility. Those enrolled will receive either the investigational medication or a placebo, administered daily for 12 weeks. Regular follow-up visits will be scheduled to monitor blood pressure and overall health. A placebo is a substance with no therapeutic effect, used as a control in testing new drugs.